264 related articles for article (PubMed ID: 17049635)
1. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
Cheng AS; Banning AP; Mitchell AR; Neubauer S; Selvanayagam JB
Int J Cardiol; 2006 Oct; 113(1):E21-3. PubMed ID: 17049635
[TBL] [Abstract][Full Text] [Related]
2. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
Vogelsberg H; Mahrholdt H; Deluigi CC; Yilmaz A; Kispert EM; Greulich S; Klingel K; Kandolf R; Sechtem U
J Am Coll Cardiol; 2008 Mar; 51(10):1022-30. PubMed ID: 18325442
[TBL] [Abstract][Full Text] [Related]
5. Amyloidosis and cardiac involvement.
Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
[TBL] [Abstract][Full Text] [Related]
6. [Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis].
Zhu KB; Cheng ZW; Tian Z; Zhao DC; Liu YT; Lin X; Chen TB; Xie HZ; Zeng Y; Fang LG; Jiang XC; Cui QC; Fang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):915-9. PubMed ID: 22321275
[TBL] [Abstract][Full Text] [Related]
7. [Cardiac amyloidosis--cardiovascular magnetic resonance imaging as a valuable diagnostic tool].
Braun G; Sechtem U; Mahrholdt H
Dtsch Med Wochenschr; 2009 Apr; 134(15):734-7. PubMed ID: 19340749
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease.
Rutten FH; Vonken EJ; Cramer MJ; Moons KG; Velthuis BB; Prakken NH; Lammers JW; Grobbee DE; Mali WP; Hoes AW
Am Heart J; 2008 Sep; 156(3):506-12. PubMed ID: 18760133
[TBL] [Abstract][Full Text] [Related]
9. Cardiac amyloidosis: MR imaging findings and T1 quantification, comparison with control subjects.
Krombach GA; Hahn C; Tomars M; Buecker A; Grawe A; Günther RW; Kühl HP
J Magn Reson Imaging; 2007 Jun; 25(6):1283-7. PubMed ID: 17520735
[TBL] [Abstract][Full Text] [Related]
10. [M-mode and two-dimensional echocardiography of 7 cases of cardiac amyloidosis].
Roudaut R; Haissaguerre M; Dallocchio M
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1525-31. PubMed ID: 6240237
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and cardiac imaging features of patients with cardiac amyloidosis].
Zhao L; Tian Z; Fang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):960-4. PubMed ID: 26888807
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis.
Sparrow P; Amirabadi A; Sussman MS; Paul N; Merchant N
J Magn Reson Imaging; 2009 Nov; 30(5):942-6. PubMed ID: 19780184
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome.
Wassmuth R; Göbel U; Natusch A; Schneider W; Kettritz R; Dietz R; Luft FC; Schulz-Menger J
J Card Fail; 2008 Dec; 14(10):856-60. PubMed ID: 19041050
[TBL] [Abstract][Full Text] [Related]
14. [A case of primary cardiac amyloidosis with amyloid A protein].
Aouda A; Toyozaki T; Saito T; Yorimitsu K; Miyazaki A; Deguchi F; Inagaki Y
Kokyu To Junkan; 1993 Jan; 41(1):89-92. PubMed ID: 8434166
[TBL] [Abstract][Full Text] [Related]
15. Cardiac amyloidosis--a case report.
Dalvi BV; Pinto R; Vora IM; Munsi SC; Vengsarkar AS
Indian Heart J; 1989; 41(5):341-3. PubMed ID: 2599548
[TBL] [Abstract][Full Text] [Related]
16. [Restrictive cardiomyopathy as a manifestation of primary amyloidosis].
Brychta T; Parenica J; Zatocil T; Manousek J; Tesák M; Schildberger J; Kala P; Semrád B; Brázdil J; Cíhalová M
Vnitr Lek; 2004 Jan; 50(1):66-71. PubMed ID: 15015232
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis: new insights into diagnosis and management.
Eshaghian S; Kaul S; Shah PK
Rev Cardiovasc Med; 2007; 8(4):189-99. PubMed ID: 18192942
[TBL] [Abstract][Full Text] [Related]
18. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
[TBL] [Abstract][Full Text] [Related]
19. Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis.
Bucciarelli-Ducci C; Locca D; Barbeau G; Prasad SK
Eur Heart J; 2007 May; 28(10):1186. PubMed ID: 17121755
[No Abstract] [Full Text] [Related]
20. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis.
Hosch W; Bock M; Libicher M; Ley S; Hegenbart U; Dengler TJ; Katus HA; Kauczor HU; Kauffmann GW; Kristen AV
Invest Radiol; 2007 Sep; 42(9):636-42. PubMed ID: 17700279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
